These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15316900)

  • 41. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast-conserving therapy after neoadjuvant chemotherapy: long-term results.
    Beriwal S; Schwartz GF; Komarnicky L; Garcia-Young JA
    Breast J; 2006; 12(2):159-64. PubMed ID: 16509842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of HER-2 status on local recurrence in women with stage I-II breast cancer treated with breast-conserving therapy.
    Harris EE; Hwang WT; Lee EA; Cengel KA; Feldman MD; Demichele A; Kao G; Solin LJ
    Breast J; 2006; 12(5):431-6. PubMed ID: 16958961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The treatment outcome of patients undergoing breast-conserving therapy: the clinical role of postoperative radiotherapy.
    Oouchi A; Sakata K; Masuoka H; Tamakawa M; Nagakura H; Someya M; Nakata K; Asaishi K; Okazaki M; Okazaki Y; Ohmura T; Hareyama M; Hori M; Shimokawara I; Okazaki A; Watanabe Y; Yamada T; Yuyama T; Satoh T; Hirata K
    Breast Cancer; 2009; 16(1):49-57. PubMed ID: 18841332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selecting patients for breast-conserving therapy: the importance of lobular histology.
    Morrow M; Keeney K; Scholtens D; Wei J; Steel J; Khan SA
    Cancer; 2006 Jun; 106(12):2563-8. PubMed ID: 16683225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
    Ben-David MA; Kleer CG; Paramagul C; Griffith KA; Pierce LJ
    Cancer; 2006 Jan; 106(1):28-34. PubMed ID: 16329136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A prospective multicenter clinical trial of breast conserving therapy for early breast cancer in China].
    Zhang BN; Shao ZM; Qiao XM; Li B; Jiang J; Yang MT; Wang S; Song ST; Zhang B; Yang HJ
    Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):680-4. PubMed ID: 16438891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes after breast conservation treatment with radiation in women with prior nonbreast malignancy and subsequent invasive breast carcinoma.
    Nemani D; Vapiwala N; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1055-60. PubMed ID: 18929447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.
    de Bock GH; van der Hage JA; Putter H; Bonnema J; Bartelink H; van de Velde CJ
    Eur J Cancer; 2006 Feb; 42(3):351-6. PubMed ID: 16314086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
    Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
    Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
    Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
    Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
    J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regional radiotherapy may improve outcomes in patients with early stage breast cancer undergoing breast conservation therapy.
    Mai GT; Choo E; Yang JL; Cooke B; Dumitru D; Lonergan D; Lewis CR
    Anticancer Res; 2007; 27(1B):647-52. PubMed ID: 17348455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
    Galper S; Blood E; Gelman R; Abner A; Recht A; Kohli A; Wong JS; Smith D; Bellon J; Connolly J; Schnitt S; Winer E; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):348-57. PubMed ID: 15667952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.